Candel Therapeutics (NASDAQ:CADL – Get Rating) is one of 259 publicly-traded companies in the “Biological products, except diagnostic” industry, but how does it contrast to its peers? We will compare Candel Therapeutics to similar companies based on the strength of its profitability, analyst recommendations, valuation, institutional ownership, earnings, risk and dividends. Institutional and Insider Ownership […]
